4th Quarter - Report

ALLERGAN, INC. for ALLERGAN, INC.

Period 4th Quarter 2009 Filed Jan 20, 2010 Signed by JENNIE UNGER EDDY, ATTORNEY & AGENT FOR FILER

Official filing
Firm
ALLERGAN, INC.
Client
ALLERGAN, INC.
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 3200/S.1796: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009/AMERICA'S HEALTHY FUTURE ACT OF 2009; ISSUES RELATED TO FOLLOW-ON BIOLOGICS, BIOSIMILARS, COSMETIC TAX GENERAL DISCUSSIONS REGARDING ISSUES REALTED TO LUMIGAN AND LATISSE

LobbyistCovered position, as disclosed
EDWARD C RENO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1796 (111th), H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.